Product Information
MICROGESTIN FE 1.5-30 TAB is a generic product labeled by Mayne Pharma, priced at $0.1484 per EA under NDC 51862087006. Its NADAC has been published 198 times since Oct 20, 2021.
FDA first approved this application on Aug 23, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mayne PharmaNDC
51862087006
Classification
Generic
Dosage Form
KIT
Effective Date
7/23/2025
Approval Type
Generic (ANDA)
FDA Application
ANDA091453FDA Approved
8/23/2013
TE Code
AB
On Market Since
10/12/2020
Price Statistics
The NADAC for MICROGESTIN FE 1.5-30 TAB has been published 198 times since Oct 20, 2021, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1484 per EA |
|---|---|
| All-time high | $0.3525 (Dec 15, 2021) |
| All-time low | $0.1170 (May 22, 2024) |
| Median price | $0.1711 |
| Average price | $0.1882 |
| Largest weekly change | +29.4% (Jun 19, 2024) |
| Weeks tracked | 198 |
| Tracking since | Oct 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.3%
5Y
N/A
All
-51.5%
Last surveyed Jul 30, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICROGESTIN FE 1.5-30 TAB?
The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN FE 1.5-30 TAB, manufactured by Mayne Pharma, is $0.1484 per EA (NDC 51862087006), effective Jul 30, 2025.
How has the price of MICROGESTIN FE 1.5-30 TAB changed over time?
Over the history we have for it, the NADAC for MICROGESTIN FE 1.5-30 TAB has declined 51.5%. It has been tracked across 198 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for MICROGESTIN FE 1.5-30 TAB?
Since Oct 20, 2021, the NADAC for MICROGESTIN FE 1.5-30 TAB has ranged from a low of $0.1170 (May 22, 2024) to a high of $0.3525 (Dec 15, 2021), with a median of $0.1711 per EA.
Are there cheaper alternatives to MICROGESTIN FE 1.5-30 TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MICROGESTIN FE 1-20 TABLET, is $0.1287 per EA — about 13% below MICROGESTIN FE 1.5-30 TAB.
Who manufactures MICROGESTIN FE 1.5-30 TAB?
MICROGESTIN FE 1.5-30 TAB (NDC 51862087006) is labeled by Mayne Pharma, and CMS classifies it as a generic product.